img

Global Dry Eye Disease Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dry Eye Disease Drug Market Insights, Forecast to 2034

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Global Dry Eye Disease Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Dry Eye Disease Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Dry Eye Disease Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Dry Eye Disease Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other

Segment by Application


Hospital
Retail Pharmacy
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Dry Eye Disease Drug plant distribution, commercial date of Dry Eye Disease Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Dry Eye Disease Drug introduction, etc. Dry Eye Disease Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Dry Eye Disease Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Dry Eye Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Dry Eye Disease Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dry Eye Disease Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dry Eye Disease Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Dry Eye Disease Drug Revenue by Region
2.2.1 Global Dry Eye Disease Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Dry Eye Disease Drug Revenue by Region (2018-2024)
2.2.3 Global Dry Eye Disease Drug Revenue by Region (2024-2029)
2.2.4 Global Dry Eye Disease Drug Revenue Market Share by Region (2018-2029)
2.3 Global Dry Eye Disease Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Dry Eye Disease Drug Sales by Region
2.4.1 Global Dry Eye Disease Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Dry Eye Disease Drug Sales by Region (2018-2024)
2.4.3 Global Dry Eye Disease Drug Sales by Region (2024-2029)
2.4.4 Global Dry Eye Disease Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dry Eye Disease Drug Sales by Manufacturers
3.1.1 Global Dry Eye Disease Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Dry Eye Disease Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dry Eye Disease Drug in 2022
3.2 Global Dry Eye Disease Drug Revenue by Manufacturers
3.2.1 Global Dry Eye Disease Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Dry Eye Disease Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dry Eye Disease Drug Revenue in 2022
3.3 Global Key Players of Dry Eye Disease Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Dry Eye Disease Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dry Eye Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dry Eye Disease Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dry Eye Disease Drug, Product Offered and Application
3.8 Global Key Manufacturers of Dry Eye Disease Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dry Eye Disease Drug Sales by Type
4.1.1 Global Dry Eye Disease Drug Historical Sales by Type (2018-2024)
4.1.2 Global Dry Eye Disease Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
4.2 Global Dry Eye Disease Drug Revenue by Type
4.2.1 Global Dry Eye Disease Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Dry Eye Disease Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
4.3 Global Dry Eye Disease Drug Price by Type
4.3.1 Global Dry Eye Disease Drug Price by Type (2018-2024)
4.3.2 Global Dry Eye Disease Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Dry Eye Disease Drug Sales by Application
5.1.1 Global Dry Eye Disease Drug Historical Sales by Application (2018-2024)
5.1.2 Global Dry Eye Disease Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
5.2 Global Dry Eye Disease Drug Revenue by Application
5.2.1 Global Dry Eye Disease Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Dry Eye Disease Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
5.3 Global Dry Eye Disease Drug Price by Application
5.3.1 Global Dry Eye Disease Drug Price by Application (2018-2024)
5.3.2 Global Dry Eye Disease Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Dry Eye Disease Drug Market Size by Type
6.1.1 US & Canada Dry Eye Disease Drug Sales by Type (2018-2029)
6.1.2 US & Canada Dry Eye Disease Drug Revenue by Type (2018-2029)
6.2 US & Canada Dry Eye Disease Drug Market Size by Application
6.2.1 US & Canada Dry Eye Disease Drug Sales by Application (2018-2029)
6.2.2 US & Canada Dry Eye Disease Drug Revenue by Application (2018-2029)
6.3 US & Canada Dry Eye Disease Drug Market Size by Country
6.3.1 US & Canada Dry Eye Disease Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Dry Eye Disease Drug Sales by Country (2018-2029)
6.3.3 US & Canada Dry Eye Disease Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dry Eye Disease Drug Market Size by Type
7.1.1 Europe Dry Eye Disease Drug Sales by Type (2018-2029)
7.1.2 Europe Dry Eye Disease Drug Revenue by Type (2018-2029)
7.2 Europe Dry Eye Disease Drug Market Size by Application
7.2.1 Europe Dry Eye Disease Drug Sales by Application (2018-2029)
7.2.2 Europe Dry Eye Disease Drug Revenue by Application (2018-2029)
7.3 Europe Dry Eye Disease Drug Market Size by Country
7.3.1 Europe Dry Eye Disease Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Dry Eye Disease Drug Sales by Country (2018-2029)
7.3.3 Europe Dry Eye Disease Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dry Eye Disease Drug Market Size
8.1.1 China Dry Eye Disease Drug Sales (2018-2029)
8.1.2 China Dry Eye Disease Drug Revenue (2018-2029)
8.2 China Dry Eye Disease Drug Market Size by Application
8.2.1 China Dry Eye Disease Drug Sales by Application (2018-2029)
8.2.2 China Dry Eye Disease Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Dry Eye Disease Drug Market Size by Type
9.1.1 Asia Dry Eye Disease Drug Sales by Type (2018-2029)
9.1.2 Asia Dry Eye Disease Drug Revenue by Type (2018-2029)
9.2 Asia Dry Eye Disease Drug Market Size by Application
9.2.1 Asia Dry Eye Disease Drug Sales by Application (2018-2029)
9.2.2 Asia Dry Eye Disease Drug Revenue by Application (2018-2029)
9.3 Asia Dry Eye Disease Drug Sales by Region
9.3.1 Asia Dry Eye Disease Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Dry Eye Disease Drug Revenue by Region (2018-2029)
9.3.3 Asia Dry Eye Disease Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dry Eye Disease Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Dry Eye Disease Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Overview
11.1.3 Allergan Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Allergan Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Alcon
11.2.1 Alcon Company Information
11.2.2 Alcon Overview
11.2.3 Alcon Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Alcon Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alcon Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Santen Pharma
11.4.1 Santen Pharma Company Information
11.4.2 Santen Pharma Overview
11.4.3 Santen Pharma Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Santen Pharma Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Santen Pharma Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Johnson & Johnson Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Bausch & Lomb
11.6.1 Bausch & Lomb Company Information
11.6.2 Bausch & Lomb Overview
11.6.3 Bausch & Lomb Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bausch & Lomb Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bausch & Lomb Recent Developments
11.7 Thea pharmaceuticals
11.7.1 Thea pharmaceuticals Company Information
11.7.2 Thea pharmaceuticals Overview
11.7.3 Thea pharmaceuticals Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Thea pharmaceuticals Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Thea pharmaceuticals Recent Developments
11.8 URSAPHARM
11.8.1 URSAPHARM Company Information
11.8.2 URSAPHARM Overview
11.8.3 URSAPHARM Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 URSAPHARM Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 URSAPHARM Recent Developments
11.9 SIMILASAN
11.9.1 SIMILASAN Company Information
11.9.2 SIMILASAN Overview
11.9.3 SIMILASAN Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 SIMILASAN Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SIMILASAN Recent Developments
11.10 Akorn
11.10.1 Akorn Company Information
11.10.2 Akorn Overview
11.10.3 Akorn Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Akorn Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Akorn Recent Developments
11.11 United Laboratories
11.11.1 United Laboratories Company Information
11.11.2 United Laboratories Overview
11.11.3 United Laboratories Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 United Laboratories Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 United Laboratories Recent Developments
11.12 Sun Pharmaceutical
11.12.1 Sun Pharmaceutical Company Information
11.12.2 Sun Pharmaceutical Overview
11.12.3 Sun Pharmaceutical Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Sun Pharmaceutical Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sun Pharmaceutical Recent Developments
11.13 Jianfeng Group
11.13.1 Jianfeng Group Company Information
11.13.2 Jianfeng Group Overview
11.13.3 Jianfeng Group Dry Eye Disease Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Jianfeng Group Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jianfeng Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dry Eye Disease Drug Industry Chain Analysis
12.2 Dry Eye Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dry Eye Disease Drug Production Mode & Process
12.4 Dry Eye Disease Drug Sales and Marketing
12.4.1 Dry Eye Disease Drug Sales Channels
12.4.2 Dry Eye Disease Drug Distributors
12.5 Dry Eye Disease Drug Customers
13 Market Dynamics
13.1 Dry Eye Disease Drug Industry Trends
13.2 Dry Eye Disease Drug Market Drivers
13.3 Dry Eye Disease Drug Market Challenges
13.4 Dry Eye Disease Drug Market Restraints
14 Key Findings in The Global Dry Eye Disease Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Dry Eye Disease Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Artificial Tears
Table 3. Major Manufacturers of Anti-inflammatory Drugs
Table 4. Major Manufacturers of Other
Table 5. Global Dry Eye Disease Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Dry Eye Disease Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Dry Eye Disease Drug Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Dry Eye Disease Drug Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Dry Eye Disease Drug Revenue Market Share by Region (2018-2024)
Table 10. Global Dry Eye Disease Drug Revenue Market Share by Region (2024-2029)
Table 11. Global Dry Eye Disease Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Dry Eye Disease Drug Sales by Region (2018-2024) & (K Units)
Table 13. Global Dry Eye Disease Drug Sales by Region (2024-2029) & (K Units)
Table 14. Global Dry Eye Disease Drug Sales Market Share by Region (2018-2024)
Table 15. Global Dry Eye Disease Drug Sales Market Share by Region (2024-2029)
Table 16. Global Dry Eye Disease Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Dry Eye Disease Drug Sales Share by Manufacturers (2018-2024)
Table 18. Global Dry Eye Disease Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Dry Eye Disease Drug Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Dry Eye Disease Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Dry Eye Disease Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Dry Eye Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Dry Eye Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Disease Drug as of 2022)
Table 24. Global Key Manufacturers of Dry Eye Disease Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Dry Eye Disease Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Dry Eye Disease Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 29. Global Dry Eye Disease Drug Sales by Type (2024-2029) & (K Units)
Table 30. Global Dry Eye Disease Drug Sales Share by Type (2018-2024)
Table 31. Global Dry Eye Disease Drug Sales Share by Type (2024-2029)
Table 32. Global Dry Eye Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Dry Eye Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Dry Eye Disease Drug Revenue Share by Type (2018-2024)
Table 35. Global Dry Eye Disease Drug Revenue Share by Type (2024-2029)
Table 36. Dry Eye Disease Drug Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Dry Eye Disease Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Dry Eye Disease Drug Sales by Application (2018-2024) & (K Units)
Table 39. Global Dry Eye Disease Drug Sales by Application (2024-2029) & (K Units)
Table 40. Global Dry Eye Disease Drug Sales Share by Application (2018-2024)
Table 41. Global Dry Eye Disease Drug Sales Share by Application (2024-2029)
Table 42. Global Dry Eye Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Dry Eye Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Dry Eye Disease Drug Revenue Share by Application (2018-2024)
Table 45. Global Dry Eye Disease Drug Revenue Share by Application (2024-2029)
Table 46. Dry Eye Disease Drug Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Dry Eye Disease Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Dry Eye Disease Drug Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Dry Eye Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Dry Eye Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Dry Eye Disease Drug Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Dry Eye Disease Drug Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Dry Eye Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Dry Eye Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Dry Eye Disease Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Dry Eye Disease Drug Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Dry Eye Disease Drug Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 61. Europe Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 62. Europe Dry Eye Disease Drug Sales by Type (2024-2029) & (K Units)
Table 63. Europe Dry Eye Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Dry Eye Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Dry Eye Disease Drug Sales by Application (2018-2024) & (K Units)
Table 66. Europe Dry Eye Disease Drug Sales by Application (2024-2029) & (K Units)
Table 67. Europe Dry Eye Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Dry Eye Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Dry Eye Disease Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Dry Eye Disease Drug Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Dry Eye Disease Drug Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 73. Europe Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 74. China Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 75. China Dry Eye Disease Drug Sales by Type (2024-2029) & (K Units)
Table 76. China Dry Eye Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Dry Eye Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Dry Eye Disease Drug Sales by Application (2018-2024) & (K Units)
Table 79. China Dry Eye Disease Drug Sales by Application (2024-2029) & (K Units)
Table 80. China Dry Eye Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Dry Eye Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 83. Asia Dry Eye Disease Drug Sales by Type (2024-2029) & (K Units)
Table 84. Asia Dry Eye Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Dry Eye Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Dry Eye Disease Drug Sales by Application (2018-2024) & (K Units)
Table 87. Asia Dry Eye Disease Drug Sales by Application (2024-2029) & (K Units)
Table 88. Asia Dry Eye Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Dry Eye Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Dry Eye Disease Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Dry Eye Disease Drug Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Dry Eye Disease Drug Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Dry Eye Disease Drug Sales by Region (2018-2024) & (K Units)
Table 94. Asia Dry Eye Disease Drug Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 108. Allergan Company Information
Table 109. Allergan Description and Major Businesses
Table 110. Allergan Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Allergan Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Allergan Recent Developments
Table 113. Alcon Company Information
Table 114. Alcon Description and Major Businesses
Table 115. Alcon Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Alcon Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Alcon Recent Developments
Table 118. Novartis Company Information
Table 119. Novartis Description and Major Businesses
Table 120. Novartis Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Novartis Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novartis Recent Developments
Table 123. Santen Pharma Company Information
Table 124. Santen Pharma Description and Major Businesses
Table 125. Santen Pharma Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Santen Pharma Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Santen Pharma Recent Developments
Table 128. Johnson & Johnson Company Information
Table 129. Johnson & Johnson Description and Major Businesses
Table 130. Johnson & Johnson Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Johnson & Johnson Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Johnson & Johnson Recent Developments
Table 133. Bausch & Lomb Company Information
Table 134. Bausch & Lomb Description and Major Businesses
Table 135. Bausch & Lomb Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Bausch & Lomb Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Bausch & Lomb Recent Developments
Table 138. Thea pharmaceuticals Company Information
Table 139. Thea pharmaceuticals Description and Major Businesses
Table 140. Thea pharmaceuticals Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Thea pharmaceuticals Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Thea pharmaceuticals Recent Developments
Table 143. URSAPHARM Company Information
Table 144. URSAPHARM Description and Major Businesses
Table 145. URSAPHARM Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. URSAPHARM Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. URSAPHARM Recent Developments
Table 148. SIMILASAN Company Information
Table 149. SIMILASAN Description and Major Businesses
Table 150. SIMILASAN Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. SIMILASAN Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. SIMILASAN Recent Developments
Table 153. Akorn Company Information
Table 154. Akorn Description and Major Businesses
Table 155. Akorn Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Akorn Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Akorn Recent Developments
Table 158. United Laboratories Company Information
Table 159. United Laboratories Description and Major Businesses
Table 160. United Laboratories Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. United Laboratories Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. United Laboratories Recent Developments
Table 163. Sun Pharmaceutical Company Information
Table 164. Sun Pharmaceutical Description and Major Businesses
Table 165. Sun Pharmaceutical Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Sun Pharmaceutical Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Sun Pharmaceutical Recent Developments
Table 168. Jianfeng Group Company Information
Table 169. Jianfeng Group Description and Major Businesses
Table 170. Jianfeng Group Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Jianfeng Group Dry Eye Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Jianfeng Group Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Dry Eye Disease Drug Distributors List
Table 176. Dry Eye Disease Drug Customers List
Table 177. Dry Eye Disease Drug Market Trends
Table 178. Dry Eye Disease Drug Market Drivers
Table 179. Dry Eye Disease Drug Market Challenges
Table 180. Dry Eye Disease Drug Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Disease Drug Product Picture
Figure 2. Global Dry Eye Disease Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Dry Eye Disease Drug Market Share by Type in 2022 & 2029
Figure 4. Artificial Tears Product Picture
Figure 5. Anti-inflammatory Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Dry Eye Disease Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Dry Eye Disease Drug Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Others
Figure 12. Dry Eye Disease Drug Report Years Considered
Figure 13. Global Dry Eye Disease Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Dry Eye Disease Drug Revenue 2018-2029 (US$ Million)
Figure 15. Global Dry Eye Disease Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Dry Eye Disease Drug Revenue Market Share by Region (2018-2029)
Figure 17. Global Dry Eye Disease Drug Sales 2018-2029 ((K Units)
Figure 18. Global Dry Eye Disease Drug Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Dry Eye Disease Drug Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Dry Eye Disease Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Dry Eye Disease Drug Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Dry Eye Disease Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Dry Eye Disease Drug Sales YoY (2018-2029) & (K Units)
Figure 24. China Dry Eye Disease Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Dry Eye Disease Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Dry Eye Disease Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Dry Eye Disease Drug Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Dry Eye Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Dry Eye Disease Drug in the World: Market Share by Dry Eye Disease Drug Revenue in 2022
Figure 31. Global Dry Eye Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
Figure 33. Global Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
Figure 34. Global Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
Figure 35. Global Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Dry Eye Disease Drug Revenue Share by Country (2018-2029)
Figure 41. US & Canada Dry Eye Disease Drug Sales Share by Country (2018-2029)
Figure 42. U.S. Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
Figure 45. Europe Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
Figure 46. Europe Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
Figure 47. Europe Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
Figure 48. Europe Dry Eye Disease Drug Revenue Share by Country (2018-2029)
Figure 49. Europe Dry Eye Disease Drug Sales Share by Country (2018-2029)
Figure 50. Germany Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 51. France Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 55. China Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
Figure 56. China Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
Figure 57. China Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
Figure 58. China Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
Figure 59. Asia Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
Figure 60. Asia Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
Figure 61. Asia Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
Figure 62. Asia Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
Figure 63. Asia Dry Eye Disease Drug Revenue Share by Region (2018-2029)
Figure 64. Asia Dry Eye Disease Drug Sales Share by Region (2018-2029)
Figure 65. Japan Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 69. India Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Dry Eye Disease Drug Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Dry Eye Disease Drug Sales Share by Country (2018-2029)
Figure 76. Brazil Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Dry Eye Disease Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Dry Eye Disease Drug Value Chain
Figure 82. Dry Eye Disease Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries